Press Resease

Organ Transplant Immunosuppressant Drugs Market by Drug Class (Antibodies, Steroids, mTOR Inhibitor, Antiproliferative Agents and Calcineurin Inhibitors); by Transplant Type (Pancreas, Lung, Heart, Liver, Kidney and Other); by Distribution Channel (Online Pharmacies, Retail Pharmacies and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Published Date: 07-Nov-2019 Category: Pharmaceutical Report Format : PDF Pages: 126 Report Code: ZMR-5014 Status : Published

Global demand for organ transplant immunosuppressant drugs market was valued at approximately USD 4.51 billion in 2018, and is expected to generate revenue of around USD 5.79 billion by end of 2025, growing at a CAGR of around 3.7% between 2019 and 2025.

Description

The report covers forecast and analysis for the organ transplant immunosuppressant drugs market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the organ transplant immunosuppressant drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the organ transplant immunosuppressant drugs market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the organ transplant immunosuppressant drugs market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the organ transplant immunosuppressant drugs market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new drug class launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the organ transplant immunosuppressant drugs market on global and regional basis.

The study provides a crucial view on the organ transplant immunosuppressant drugs by segmenting the market based on drug class, Transplant Type,  and region. All the segments of organ transplant immunosuppressant drugs market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Organ transplant refers to a medical procedure wherein donor organ is transplanted in body of a recipient to replace missing or damaged organ. Autograft is transplant type wherein organs or tissues are transplanted in the same person’s body. Allograft can be from cadaveric or living source and refers to transplant between two subjects of the same species. Organ transplantation is usually done no other treatment works or in case of end state organ failure such as kidney, heart, liver failure. The immune system may attack the newly transplanted organ if donor and recipients are not matched. Transplant rejection is quite common and the person with transplanted organ has to take immunosuppressant drugs for lifetime.

The demand for organ transplant immunosuppressant drugs market is driven by growing demand for transplantation, increasing investment for research and development in tissue engineering, technological advancements in organ transplant. Increasing chronic disease burden is another factor that is contributing to the organ transplant immunosuppressant drugs market growth. However, low availability of organs and high cost of overall transplantation procedure may hamper the market growth.

Based on drug class, global organ transplant immunosuppressant drugs market is bifurcated into antibodies, steroids, mTOR inhibitor, antiproliferative agents and calcineurin inhibitors. Calcineurin inhibitors drug class segment held largest market share in 2018 whereas antibodies segment is expected to exhibit highest CAGR over the forecast period. Calcineurin inhibitors drug class includes majorly two drugs cyclosporine and tacrolimus. These effective drugs have widely been used for almost 20 years.

Based on transplant type global organ transplant immunosuppressant drugs market is bifurcated into pancreas, lung, heart, liver, kidney and other. Kidney transplant was the most common transplant type across the globe in 2018. This is attributed to comparatively easy availability of donor organs compared to other organs. Also, kidney transplant is more cost effective as compared to prolonged periods of dialysis.

Based on distribution channel global organ transplant immunosuppressant drugs market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies. Hospital pharmacies held leading market share in 2018 since it is most widely preferred channel of distribution.

North America represents developed regional market for organ transplant immunosuppressant drugs. Presence of favorable reimbursement policies, presence of developed healthcare facilities, technological advancements, increasing healthcare spending are major factors driving the market growth in this region. Europe was second largest market in 2018. Asia Pacific is projected to witness rapid CAGR for organ transplant immunosuppressant drugs market. Dense population base, increasing chronic disease burden, increasing healthcare expenditure, introduction of favorable reimbursement policies are expected to boost market growth in Asia Pacific. Latin America is will register noticeable growth over the forecast period. Middle East and Africa will register sluggish growth in the years to come as a result of lack of advanced healthcare infrastructure.

Major players included in the report are Bristol-Myers Squibb Company, Veloxis Pharmaceuticals A/S, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Mylan Laboratories, Inc., Novartis AG, Accord Healthcare Ltd., Sanofi Genzyme, and Astellas Pharma, Inc. among others.

The report segment of global organ transplant immunosuppressant drugs market as follows:

Global Organ Transplant Immunosuppressant Drugs Market: By Drug Class

  • Calcineurin Inhibitors
  • Antiproliferative Agents
  • mTOR Inhibitor
  • Steroids
  • Antibodies

Global Organ Transplant Immunosuppressant Drugs Market: By Transplant Type

  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • Other

Global Organ Transplant Immunosuppressant Drugs Market: By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Organ Transplant Immunosuppressant Drugs Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
    • 2.2. Organ Transplant Immunosuppressant Drugs Market: Snapshot
  • Chapter 3. Organ Transplant Immunosuppressant Drugs Market - Industry Analysis
    • 3.1. Organ Transplant Immunosuppressant Drugs Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By Transplant Type
      • 3.6.3. Market attractiveness analysis By Distribution Channel
      • 3.6.4. Market attractiveness analysis By Region
  • Chapter 4. Organ Transplant Immunosuppressant Drugs Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Organ Transplant Immunosuppressant Drugs Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Organ Transplant Immunosuppressant Drugs Market - Drug Class Analysis
    • 5.1. Global Organ Transplant Immunosuppressant Drugs Market overview: By Drug Class
      • 5.1.1. Global Organ Transplant Immunosuppressant Drugs Market share, By Product,2018 and 2025
    • 5.2. Calcineurin Inhibitors
      • 5.2.1. Global Organ Transplant Immunosuppressant Drugs Market By Product1, 2016-2025 (USD Million)
    • 5.3. Antiproliferative Agents
      • 5.3.1. Global Organ Transplant Immunosuppressant Drugs Market By Product2, 2016-2025 (USD Million)
    • 5.4. mTOR Inhibitor
      • 5.4.1. Global Organ Transplant Immunosuppressant Drugs Market By Product3, 2016-2025 (USD Million)
    • 5.5. Steroids
      • 5.5.1. Global Organ Transplant Immunosuppressant Drugs Market By Product4, 2016-2025 (USD Million)
    • 5.6. Antibodies
      • 5.6.1. Global Organ Transplant Immunosuppressant Drugs Market By Antibodies, 2016-2025 (USD Million)
  • Chapter 6. Global Organ Transplant Immunosuppressant Drugs Market -Transplant Type Analysis
    • 6.1. Global Organ Transplant Immunosuppressant Drugs Market overview: By Transplant Type
      • 6.1.1. Global Organ Transplant Immunosuppressant Drugs Market share, By Transplant Type, 2018 and 2025
    • 6.2. Kidney
      • 6.2.1. Global Organ Transplant Immunosuppressant Drugs Market By Kidney, 2016-2025 (USD Million)
    • 6.3. Liver
      • 6.3.1. Global Organ Transplant Immunosuppressant Drugs Market By Liver, 2016-2025 (USD Million)
    • 6.4. Heart
      • 6.4.1. Global Organ Transplant Immunosuppressant Drugs Market By Heart, 2016-2025 (USD Million)
    • 6.5. Lung
      • 6.5.1. Global Organ Transplant Immunosuppressant Drugs Market By Lung, 2016-2025 (USD Million)
    • 6.6. Pancreas
      • 6.6.1. Global Organ Transplant Immunosuppressant Drugs Market By PancreasTransplant Types, 2016-2025 (USD Million)
    • 6.7. Others
      • 6.7.1. Global Organ Transplant Immunosuppressant Drugs Market By Other Transplant Types, 2016-2025 (USD Million)
  • Chapter 7. Global Organ Transplant Immunosuppressant Drugs Market -Distribution Channel Analysis
    • 7.1. Global Organ Transplant Immunosuppressant Drugs Market overview: By Distribution Channel
      • 7.1.1. Global Organ Transplant Immunosuppressant Drugs Marketshare, By Distribution Channel, 2018 and 2025
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Organ Transplant Immunosuppressant Drugs Market By Hospital Pharmacies, 2016-2025 (USD Million)
    • 7.3. Retail Pharmacies
      • 7.3.1. Global Organ Transplant Immunosuppressant Drugs Market By Retail Pharmacies, 2016-2025 (USD Million)
    • 7.4. Online Pharmacies
      • 7.4.1. Global Organ Transplant Immunosuppressant Drugs Market By Online Pharmacies, 2016-2025 (USD Million)
  • Chapter 8. Global Organ Transplant Immunosuppressant Drugs Market - Regional Analysis
    • 8.1. Global Organ Transplant Immunosuppressant Drugs Market overview: By Region
      • 8.1.1. Global Organ Transplant Immunosuppressant Drugs Marketshare, By Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
      • 8.2.2. North America Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.2.3. North America Organ Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.2.4. North America Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S.Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.5.2. The U.S.Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S.Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. EuropeOrgan Transplant Immunosuppressant Drugs Market2016-2025 (USD Million)
      • 8.3.2. Europe Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.3.3. Europe Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.3.4. Europe Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. U.K.Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.5.2. U.K.Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.3.5.3. U.K. Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.6.2. France Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.3.6.3. France Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.7.2. Germany Organ Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.3.7.3. Germany Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of EuropeOrgan Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.8.2. Rest of EuropeOrgan Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Organ Transplant Immunosuppressant Drugs Marketrevenue, By Product,2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.5.2. China Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.4.5.3. China Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.6.2. Japan Organ Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.4.6.3. Japan Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.7.2. India Organ Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.4.7.3. India Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Organ Transplant Immunosuppressant Drugs Marketrevenue, By Product,2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
      • 8.5.2. Latin America Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.5.3. Latin America Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.5.4. Latin America Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Organ Transplant Immunosuppressant Drugs Marketrevenue, By Product,2016-2025 (USD Million)
        • 8.5.5.2. Brazil Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.5.6. Rest of LatinAmerica
        • 8.5.6.1. Rest of LatinAmerica Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.5.6.2. Rest of LatinAmerica Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Marketrevenue, By Product,2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.6.4. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Bristol-Myers Squibb Company
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Veloxis Pharmaceuticals A/S
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. GlaxoSmithKline plc
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Dr. Reddy's Laboratories Ltd
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. F. Hoffmann-La Roche Ltd
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Mylan Laboratories, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Novartis AG
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Accord Healthcare Ltd.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Sanofi Genzyme
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. Astellas Pharma, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social